Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04603677 · ClinicalTrials.gov registry record
Northern Colorado COVID-19 Biobank
A clinical trial of COVID-19, sponsored by Colorado State University.
- Completed
- Registry status
- 148
- Enrollment target
- 4
- Study locations
NCT04603677: Completed study of COVID-19, sponsored by Colorado State University.
NCT04603677 is a study of COVID-19 that has completed, run by Colorado State University. The registered enrollment target is 148 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04603677, a study of COVID-19, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
- 4
- Study locations
Study Summary
The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.
Primary Outcome
Evaluation of parameters for markers of SARS-CoV-2 infection and predictors for severe disease
Conditions Studied
Study Locations (4)
Colorado
- Colorado State University - Fort Collins
- Poudre Valley Hospital, UCHealth - Fort Collins
- Greeley Hospital, UCHealth - Greeley
- Medical Center of the Rockies, UCHealth - Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2020-07-08 |
| Est. Completion | 2023-02-28 |
What the finished NCT04603677 record still lists
NCT04603677 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04603677 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04603677 about?
NCT04603677 is a clinical study titled "Northern Colorado COVID-19 Biobank". The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.
What is the current status of trial NCT04603677?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2020-07-08. Estimated completion is 2023-02-28.
What conditions does trial NCT04603677 study?
This clinical trial studies the following conditions: COVID-19.
Who is sponsoring clinical trial NCT04603677?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04603677 being conducted?
This trial has 4 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04603677's enrollment target sits among peer trials
148 177th of 298 higher than 122 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI